Shp2 Deletion in Hepatocytes Suppresses Hepatocarcinogenesis Driven by Oncogenic β-Catenin, PIK3CA and MET

BACKGROUND AND AIMS: Shp2 is an SH2-tyrosine phosphatase acting downstream of receptor tyrosine kinases (RTKs). Most recent data demonstrated a liver tumor-suppressing role for Shp2, as ablating Shp2 in hepatocytes aggravated hepatocellular carcinoma (HCC) induced by chemical carcinogen or Pten loss...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Hepatol
Huvudupphovsmän: Liu, Jacey J., Li, Yanjie, Chen, Wendy S., Liang, Yan, Wang, Gaowei, Zong, Min, Kaneko, Kota, Xu, Ruiyun, Karin, Michael, Feng, Gen-Sheng
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008184/
https://ncbi.nlm.nih.gov/pubmed/29505847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2018.02.014
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk